Chemoinformaics analysis of (4S)-1-Methyl-4-(prop-1-EN-2-YL)-7-oxabicyclo[4.1.0]heptane
Molecular Weight | 152.237 | nRot | 1 |
Heavy Atom Molecular Weight | 136.109 | nRig | 22 |
Exact Molecular Weight | 152.12 | nRing | 2 |
Solubility: LogS | -5.853 | nHRing | 1 |
Solubility: LogP | 7.024 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 1 |
No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 10 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 28.1707 |
nHD | 0 | BPOL | 17.7873 |
QED | 0.452 |
Synth | 4.649 |
Natural Product Likeliness | 3.063 |
NR-PPAR-gamma | 0.087 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.17 |
Pgp-sub | 0 |
HIA | 0.032 |
CACO-2 | -4.96 |
MDCK | 0.00000813 |
BBB | 0.688 |
PPB | 0.978047 |
VDSS | 1.487 |
FU | 0.0176132 |
CYP1A2-inh | 0.03 |
CYP1A2-sub | 0.511 |
CYP2c19-inh | 0.076 |
CYP2c19-sub | 0.972 |
CYP2c9-inh | 0.117 |
CYP2c9-sub | 0.654 |
CYP2d6-inh | 0.047 |
CYP2d6-sub | 0.645 |
CYP3a4-inh | 0.189 |
CYP3a4-sub | 0.327 |
CL | 21.093 |
T12 | 0.045 |
hERG | 0.033 |
Ames | 0.014 |
ROA | 0.045 |
SkinSen | 0.065 |
Carcinogencity | 0.031 |
EI | 0.052 |
Respiratory | 0.961 |
NR-Aromatase | 0.402 |
Antiviral | No |
Prediction | 0.944709 |